References
- Higuchi T., Connors K. A. Phase solubility techniques. Advances in Analytical Chemistry and Instrumentation, C. N. Reilley. Wiley-Interscience, New York 1965; 117–212
- Gelb R. I., Schwartz L. M., Cardelino B., Fuhrman H. S., Johnson R. F., Laufer D. A. Binding mechanisms in cyclohexaamylose complexes. J. Am. Chem. Soc. 1981; 103: 1750–1757
- Connors K. A., Pendergast D. D. Microscopic binding constants in cyclodextrin systems: complexation of α-cyclodextrin with sym-1,4-disubstituted benzenes. J. Am. Chem. Soc. 1984; 106: 7607–7614
- Uekama K., Ikeda Y., Hirayama M., Otagiri M., Shibata M. Inclusion complexation of p-hydroxybenzoic acid esters with α- and β-cyclodextrins: dissolution behaviors and antimicrobial activities. Yakugaku Zasshi 1980; 100(10)994–1003
- Connors K. A., Paulson A., Toledo-Velasquez D. Complexation of α-cyclodextrin with Sym-4,4′-disubstituted biphenyls. J. Org. Chem. 1988; 53: 2023–2026
- Bergeron R. J., Charming M. A., Gibeily G. I., Pillor D. M. Disposition requirements for binding in aqueous solution of substrates in the cyclohexaamylose cavity. J. Am. Chem. Soc 1977; 99(15)5146–5151
- Connors K. A., Lin S., Wong A. B. Potentiometric study of molecular complexes of weak acids and bases applied to complexes of α-cyclodextrin with para-substituted benzoic acids. J. Pharm. Sci. 1982; 71(2)217–222
- Sideris E. F., Valsami G. N., Koupparis M. A., Macheras P. E. Determination of association constants in cyclodextrin/drug complexation using the scatchard plot: application to β-cyclodextrin-anilinonaphthalene sulfonates. Pharm. Res. 1992; 9(12)1568–1574
- Anguiano-Igea S., Otero-Espinar F. J., Vila-Jato J. L., Blanco-Mendez J. Evaluation of sealed heating method for the obtention of a clofibrate/β-cyclodextrin inclusion complex. J. Pharm. Sci. 1992; 2(4)325–331
- Fromming K. H., Fridrich R., Mehnert W. Inclusion compounds of cholesterol and β-cyclodextrin. Eur. J. Pharm. Biopharm. 1993; 39(4)148–152
- Kedzierewicz F., Hoffman M., Maincent P. Comparison of tolbutamide β-cyclodextrin inclusion compounds and solid dispersants: Physichochemical characteristics and dissolution studies. Int. J. Pharm. 1990; 58: 221–227
- Frank S. G., Kavaliunas D. R. Investigation of the β-cyclodextrin-hydrocortisone inclusion compound. J. Pharm. Sci. 1983; 72(10)1215–1217
- Takahashi T., Kagami I., Kitamura K., Nakanishi Y., Imasato Y. Stabilization of ad-1590, a non-steroidal antiinflammatory agent, in suppository bases by β-cyclodextrin complexation. Chem. Pharm. Bull. 1986; 34(40)1770–1774
- Seo H., Tsuruoka M., Fujinaga T., Otagiri M., Uekama K. Enhancement of oral bioavailability of spironolactone by β- and γ-cyclodextrin complexations. Chem. Pharm. Bull. 1983; 31(1)286–291
- Owais L., Al-Omari M., Abu Malooh A., Zughul M., Badwan A. A. A novel method for preparation of betacyclodextrin complexes using colloidal mill. 6th International Conference on Pharmaceutical Technology, ParisFrance, 1992; 5: 339–348
- Schlenk H., Sand D. M. The association of α- and β-cyclodextrins with organic acids. J. Am. Chem. Soc. 1961; 83: 2312–2320
- Saenger W. Structural aspects of cyclodextrins and their inclusion compounds. Inclusion Compounds, J. L. Atwood, J. E. Davies, D. D. McNicol. Academic Press, London 1984; Vol. 2: 232–259